Waverley Pharma Incis A Specialty Pharma Company That Is Dedicated To The Development And Commercialization Of Safeeffective And Affordable Cancer Therapeuticsthe Company S Current Focus Is On The Generic Oncology Injectable Market In The European Union And North Americathe Company Has Two Lead Products Ready For Regulatory Filingand Is Currently Developing A Pipeline Of Injectable Productsthrough Multiple Partnershipsin Different Stages Of Developmentwaverley Pharma Is Committed To Providing Patients With Affordable Prescription Medicines That Lower Healthcare Costs And Provide A Better Quality Of Life
